Znanstveni rad - Izvorni znanstveni rad
Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma
Oncology Letters, 22 (2021), 6; 822. https://doi.org/10.3892/ol.2021.13083

Sremac, Maja; Paić, Frane; Ravić, Katja; Šerman, Ljiljana; Pavičić Dujmović, Aja; Brčić, Iva; Krznarić, Željko; Martić, Tamara

Citirajte ovaj rad

Sremac, M., Paić, F., Ravić, K., Šerman, Lj., Pavičić Dujmović, A., Brčić, I. ... Martić, T. (2021). Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncology Letters, 22. (6). doi: 10.3892/ol.2021.13083

Sremac, Maja, et al. "Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma." Oncology Letters, vol. 22, br. 6, 2021. https://doi.org/10.3892/ol.2021.13083

Sremac, Maja, Frane Paić, Katja Ravić, Ljiljana Šerman, Aja Pavičić Dujmović, Iva Brčić, Željko Krznarić i Tamara Martić. "Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma." Oncology Letters 22, br. 6 (2021). https://doi.org/10.3892/ol.2021.13083

Sremac, M., et al. (2021) 'Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma', Oncology Letters, 22(6). doi: 10.3892/ol.2021.13083

Sremac M, Paić F, Ravić K, Šerman Lj, Pavičić Dujmović A, Brčić I, i sur.. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncology Letters [Internet]. 08.10.2021. [pristupljeno 10.06.2022.];22(6). doi: 10.3892/ol.2021.13083

M. Sremac, et al., "Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma", Oncology Letters, vol. 22, br. 6, Listopad 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:791452. [Citirano: 10.06.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.